NCCN now endorses CSF-based profiling for biopsy-infeasible HGG/GBM to enable molecular characterization required for ...
-Delve Bio to Present Two Oral Presentations at American Academy of Neurology 2026 Annual Meeting- Delve Bio, a UCSF spin-out and pioneer in metagenomic next-generation sequencing (mNGS) for ...
Recent decades have witnessed the emergence and re-emergence of numerous medically important viruses that cause central nervous system (CNS) infections in children, e ...
Since ketamine, a N-methyl-D-aspartate (NMDA) receptor antagonist, has been shown to have rapid occurring antidepressant effects [1,2,3], there is growing interest in the NMDA receptor as potential ...
CHICAGO, April 25, 2025 /PRNewswire/ -- Belay Diagnostics, a CLIA/CAP accredited laboratory focused on the development and commercialization of molecular diagnostics targeting central nervous system ...
New peer-reviewed study from UT Southwestern Medical Center shows Summit found clinically significant variants in more than half of cytology-negative cases CHICAGO, May. 6, 2026 /PRNewswire/ -- A new ...
REDMOND, WA, UNITED STATES, January 15, 2026 /EINPresswire.com/ — The End Brain Cancer Initiative Partners with Belay Diagnostics to Raise Awareness of Diagnostic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results